stay tuned:
elixi news from the
world

New hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease

New hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease

A new research published in Neuropathology and Applied Neurobiology, has established that Toxic proteins within the brain that cause Parkinson’s disease and Lewy body dementia have the potential to help develop new targeted therapies.

Research into modified RNA messages could help treat diseases and develop new therapies

University of Nottingham experts – led by Dr Helen Miranda Knight – have discovered that the modification of ribonucleic acid (RNA) in human brain tissue is disrupted among neurodegenerative diseases. These conditions include Lewy bodies dementia and Parkinson’s disease.

You can read the full article here:

 

https://onlinelibrary.wiley.com/action/doSearch?AllField=modified+m6a&SeriesKey=13652990

 

Share this article

Tweet
Share
Pin it
Share

SEE Also

we are specialized in the procurement and distribution of pharmaceutical products, medical devices all over the world

Stay Tuned

Subscribe to our newsletter

    Headquarter

    Elixi International SA
    Vicolo Oldelli 12
    6830 Chiasso (TI)

    Switzerland

    Tel.  +41 (0)91 6822040
    info@elixi-int.com

    Subsidiary

    Elixi Europe Srl
    Via Uberti 6
    21100 Varese (VA)

    Italy

    Tel.  +41 (0)91 6822040
    europe@elixi-int.com

    Subsidiary

    Elixi Pharma pte. ltd.
    6A  Shenton way #04-01
    Downtown gallery building

    Singapore

    Tel.  +41 (0)91 6822040
    singapore@elixi-int.com

    ELIXI International SA

    Copyright 2023 ELIXI International SA.   |   All Rights Reserved   |   Privacy Policy   |   Cookie Policy